Dr. Cedric Francois | Co-Founder and CEO |
Tim Sullivan | CFO |
Adam Townsend | CCO |
Dr. Caroline Baumal | CMO |
Meredith Kaya | SVP, IR |
Jonathan Miller | Evercore ISI |
Tazeen Ahmad | Bank of America |
Anupam Rama | JPMorgan |
Colleen Kusy | Robert W. Baird |
Yigal Nochomovitz | Citigroup |
Steven Seedhouse | Raymond James |
Phil Nadeau | TD Cowen |
Justin Kim | Oppenheimer & Company |
Eliana Merle | UBS |
Annabel Samimy | Stifel Financial Corp. |
Joseph Stringer | Needham & Company |
Douglas Tsao | H.C. Wainwright |
Laura Chico | Wedbush Securities |
Good day, and thank you for standing by. Welcome to Apellis Pharmaceuticals Second Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answer session. [Operator Instructions].